Medical Care
Global Anti-viral Nasal Spray Market Research Report 2026
- Feb 24, 26
- ID: 707168
- Pages: 118
- Figures: 118
- Views: 2
This report delivers a comprehensive overview of the global Anti-viral Nasal Spray market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Anti-viral Nasal Spray. The Anti-viral Nasal Spray market size, estimates, and forecasts are provided in terms of sales volume (KG) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Anti-viral Nasal Spray market comprehensively. Regional market sizes Effective Protection Duration, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Anti-viral Nasal Spray manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, Effective Protection Duration, by Application, and by region.
Market Segmentation
By Company
pHOXBIO
Dual
Birmingham Biotech
Salvacion
BioSure
Profispray
EM Pharma
Virx
Novasci
Guangzhou Apollobio
Blue Sail Medical
Segment Effective Protection Duration
6 hours or less
6 hours or more
by Application
Children
Adults
Elderly
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (Effective Protection Duration, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Anti-viral Nasal Spray manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Anti-viral Nasal Spray sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments Effective Protection Duration, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Anti-viral Nasal Spray market comprehensively. Regional market sizes Effective Protection Duration, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Anti-viral Nasal Spray manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, Effective Protection Duration, by Application, and by region.
Market Segmentation
By Company
pHOXBIO
Dual
Birmingham Biotech
Salvacion
BioSure
Profispray
EM Pharma
Virx
Novasci
Guangzhou Apollobio
Blue Sail Medical
Segment Effective Protection Duration
6 hours or less
6 hours or more
by Application
Children
Adults
Elderly
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (Effective Protection Duration, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Anti-viral Nasal Spray manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Anti-viral Nasal Spray sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments Effective Protection Duration, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Anti-viral Nasal Spray Market Overview
1.1 Product Definition
1.2 Anti-viral Nasal Spray Effective Protection Duration
1.2.1 Global Anti-viral Nasal Spray Market Value Effective Protection Duration: 2025 vs 2032
1.2.2 6 hours or less
1.2.3 6 hours or more
1.3 Anti-viral Nasal Spray by Application
1.3.1 Global Anti-viral Nasal Spray Market Value by Application: 2025 vs 2032
1.3.2 Children
1.3.3 Adults
1.3.4 Elderly
1.4 Global Anti-viral Nasal Spray Market Size Estimates and Forecasts
1.4.1 Global Anti-viral Nasal Spray Revenue 2021–2032
1.4.2 Global Anti-viral Nasal Spray Sales 2021–2032
1.4.3 Global Anti-viral Nasal Spray Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Anti-viral Nasal Spray Market Competition by Manufacturers
2.1 Global Anti-viral Nasal Spray Sales Market Share by Manufacturers (2021–2026)
2.2 Global Anti-viral Nasal Spray Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Anti-viral Nasal Spray Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Anti-viral Nasal Spray, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Anti-viral Nasal Spray, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Anti-viral Nasal Spray, Product Types and Applications
2.7 Global Key Manufacturers of Anti-viral Nasal Spray, Date of Entry into the Industry
2.8 Global Anti-viral Nasal Spray Market Competitive Situation and Trends
2.8.1 Global Anti-viral Nasal Spray Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Anti-viral Nasal Spray Players Market Share by Revenue
2.8.3 Global Anti-viral Nasal Spray Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti-viral Nasal Spray Market Scenario by Region
3.1 Global Anti-viral Nasal Spray Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Anti-viral Nasal Spray Sales by Region: 2021–2032
3.2.1 Global Anti-viral Nasal Spray Sales by Region: 2021–2026
3.2.2 Global Anti-viral Nasal Spray Sales by Region: 2027–2032
3.3 Global Anti-viral Nasal Spray Revenue by Region: 2021–2032
3.3.1 Global Anti-viral Nasal Spray Revenue by Region: 2021–2026
3.3.2 Global Anti-viral Nasal Spray Revenue by Region: 2027–2032
3.4 North America Anti-viral Nasal Spray Market Facts & Figures by Country
3.4.1 North America Anti-viral Nasal Spray Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Anti-viral Nasal Spray Sales by Country (2021–2032)
3.4.3 North America Anti-viral Nasal Spray Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-viral Nasal Spray Market Facts & Figures by Country
3.5.1 Europe Anti-viral Nasal Spray Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Anti-viral Nasal Spray Sales by Country (2021–2032)
3.5.3 Europe Anti-viral Nasal Spray Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-viral Nasal Spray Market Facts & Figures by Region
3.6.1 Asia Pacific Anti-viral Nasal Spray Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Anti-viral Nasal Spray Sales by Region (2021–2032)
3.6.3 Asia Pacific Anti-viral Nasal Spray Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Anti-viral Nasal Spray Market Facts & Figures by Country
3.7.1 Latin America Anti-viral Nasal Spray Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Anti-viral Nasal Spray Sales by Country (2021–2032)
3.7.3 Latin America Anti-viral Nasal Spray Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Anti-viral Nasal Spray Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-viral Nasal Spray Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Anti-viral Nasal Spray Sales by Country (2021–2032)
3.8.3 Middle East and Africa Anti-viral Nasal Spray Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment Effective Protection Duration
4.1 Global Anti-viral Nasal Spray Sales Effective Protection Duration (2021–2032)
4.1.1 Global Anti-viral Nasal Spray Sales Effective Protection Duration (2021–2026)
4.1.2 Global Anti-viral Nasal Spray Sales Effective Protection Duration (2027–2032)
4.1.3 Global Anti-viral Nasal Spray Sales Market Share Effective Protection Duration (2021–2032)
4.2 Global Anti-viral Nasal Spray Revenue Effective Protection Duration (2021–2032)
4.2.1 Global Anti-viral Nasal Spray Revenue Effective Protection Duration (2021–2026)
4.2.2 Global Anti-viral Nasal Spray Revenue Effective Protection Duration (2027–2032)
4.2.3 Global Anti-viral Nasal Spray Revenue Market Share Effective Protection Duration (2021–2032)
4.3 Global Anti-viral Nasal Spray Price Effective Protection Duration (2021–2032)
5 Segment by Application
5.1 Global Anti-viral Nasal Spray Sales by Application (2021–2032)
5.1.1 Global Anti-viral Nasal Spray Sales by Application (2021–2026)
5.1.2 Global Anti-viral Nasal Spray Sales by Application (2027–2032)
5.1.3 Global Anti-viral Nasal Spray Sales Market Share by Application (2021–2032)
5.2 Global Anti-viral Nasal Spray Revenue by Application (2021–2032)
5.2.1 Global Anti-viral Nasal Spray Revenue by Application (2021–2026)
5.2.2 Global Anti-viral Nasal Spray Revenue by Application (2027–2032)
5.2.3 Global Anti-viral Nasal Spray Revenue Market Share by Application (2021–2032)
5.3 Global Anti-viral Nasal Spray Price by Application (2021–2032)
6 Key Companies Profiled
6.1 pHOXBIO
6.1.1 pHOXBIO Company Information
6.1.2 pHOXBIO Description and Business Overview
6.1.3 pHOXBIO Anti-viral Nasal Spray Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 pHOXBIO Anti-viral Nasal Spray Product Portfolio
6.1.5 pHOXBIO Recent Developments/Updates
6.2 Dual
6.2.1 Dual Company Information
6.2.2 Dual Description and Business Overview
6.2.3 Dual Anti-viral Nasal Spray Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Dual Anti-viral Nasal Spray Product Portfolio
6.2.5 Dual Recent Developments/Updates
6.3 Birmingham Biotech
6.3.1 Birmingham Biotech Company Information
6.3.2 Birmingham Biotech Description and Business Overview
6.3.3 Birmingham Biotech Anti-viral Nasal Spray Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Birmingham Biotech Anti-viral Nasal Spray Product Portfolio
6.3.5 Birmingham Biotech Recent Developments/Updates
6.4 Salvacion
6.4.1 Salvacion Company Information
6.4.2 Salvacion Description and Business Overview
6.4.3 Salvacion Anti-viral Nasal Spray Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Salvacion Anti-viral Nasal Spray Product Portfolio
6.4.5 Salvacion Recent Developments/Updates
6.5 BioSure
6.5.1 BioSure Company Information
6.5.2 BioSure Description and Business Overview
6.5.3 BioSure Anti-viral Nasal Spray Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 BioSure Anti-viral Nasal Spray Product Portfolio
6.5.5 BioSure Recent Developments/Updates
6.6 Profispray
6.6.1 Profispray Company Information
6.6.2 Profispray Description and Business Overview
6.6.3 Profispray Anti-viral Nasal Spray Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Profispray Anti-viral Nasal Spray Product Portfolio
6.6.5 Profispray Recent Developments/Updates
6.7 EM Pharma
6.7.1 EM Pharma Company Information
6.7.2 EM Pharma Description and Business Overview
6.7.3 EM Pharma Anti-viral Nasal Spray Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 EM Pharma Anti-viral Nasal Spray Product Portfolio
6.7.5 EM Pharma Recent Developments/Updates
6.8 Virx
6.8.1 Virx Company Information
6.8.2 Virx Description and Business Overview
6.8.3 Virx Anti-viral Nasal Spray Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Virx Anti-viral Nasal Spray Product Portfolio
6.8.5 Virx Recent Developments/Updates
6.9 Novasci
6.9.1 Novasci Company Information
6.9.2 Novasci Description and Business Overview
6.9.3 Novasci Anti-viral Nasal Spray Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Novasci Anti-viral Nasal Spray Product Portfolio
6.9.5 Novasci Recent Developments/Updates
6.10 Guangzhou Apollobio
6.10.1 Guangzhou Apollobio Company Information
6.10.2 Guangzhou Apollobio Description and Business Overview
6.10.3 Guangzhou Apollobio Anti-viral Nasal Spray Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Guangzhou Apollobio Anti-viral Nasal Spray Product Portfolio
6.10.5 Guangzhou Apollobio Recent Developments/Updates
6.11 Blue Sail Medical
6.11.1 Blue Sail Medical Company Information
6.11.2 Blue Sail Medical Description and Business Overview
6.11.3 Blue Sail Medical Anti-viral Nasal Spray Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Blue Sail Medical Anti-viral Nasal Spray Product Portfolio
6.11.5 Blue Sail Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-viral Nasal Spray Industry Chain Analysis
7.2 Anti-viral Nasal Spray Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-viral Nasal Spray Production Mode & Process Analysis
7.4 Anti-viral Nasal Spray Sales and Marketing
7.4.1 Anti-viral Nasal Spray Sales Channels
7.4.2 Anti-viral Nasal Spray Distributors
7.5 Anti-viral Nasal Spray Customer Analysis
8 Anti-viral Nasal Spray Market Dynamics
8.1 Anti-viral Nasal Spray Industry Trends
8.2 Anti-viral Nasal Spray Market Drivers
8.3 Anti-viral Nasal Spray Market Challenges
8.4 Anti-viral Nasal Spray Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Anti-viral Nasal Spray Effective Protection Duration
1.2.1 Global Anti-viral Nasal Spray Market Value Effective Protection Duration: 2025 vs 2032
1.2.2 6 hours or less
1.2.3 6 hours or more
1.3 Anti-viral Nasal Spray by Application
1.3.1 Global Anti-viral Nasal Spray Market Value by Application: 2025 vs 2032
1.3.2 Children
1.3.3 Adults
1.3.4 Elderly
1.4 Global Anti-viral Nasal Spray Market Size Estimates and Forecasts
1.4.1 Global Anti-viral Nasal Spray Revenue 2021–2032
1.4.2 Global Anti-viral Nasal Spray Sales 2021–2032
1.4.3 Global Anti-viral Nasal Spray Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Anti-viral Nasal Spray Market Competition by Manufacturers
2.1 Global Anti-viral Nasal Spray Sales Market Share by Manufacturers (2021–2026)
2.2 Global Anti-viral Nasal Spray Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Anti-viral Nasal Spray Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Anti-viral Nasal Spray, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Anti-viral Nasal Spray, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Anti-viral Nasal Spray, Product Types and Applications
2.7 Global Key Manufacturers of Anti-viral Nasal Spray, Date of Entry into the Industry
2.8 Global Anti-viral Nasal Spray Market Competitive Situation and Trends
2.8.1 Global Anti-viral Nasal Spray Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Anti-viral Nasal Spray Players Market Share by Revenue
2.8.3 Global Anti-viral Nasal Spray Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti-viral Nasal Spray Market Scenario by Region
3.1 Global Anti-viral Nasal Spray Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Anti-viral Nasal Spray Sales by Region: 2021–2032
3.2.1 Global Anti-viral Nasal Spray Sales by Region: 2021–2026
3.2.2 Global Anti-viral Nasal Spray Sales by Region: 2027–2032
3.3 Global Anti-viral Nasal Spray Revenue by Region: 2021–2032
3.3.1 Global Anti-viral Nasal Spray Revenue by Region: 2021–2026
3.3.2 Global Anti-viral Nasal Spray Revenue by Region: 2027–2032
3.4 North America Anti-viral Nasal Spray Market Facts & Figures by Country
3.4.1 North America Anti-viral Nasal Spray Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Anti-viral Nasal Spray Sales by Country (2021–2032)
3.4.3 North America Anti-viral Nasal Spray Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-viral Nasal Spray Market Facts & Figures by Country
3.5.1 Europe Anti-viral Nasal Spray Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Anti-viral Nasal Spray Sales by Country (2021–2032)
3.5.3 Europe Anti-viral Nasal Spray Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-viral Nasal Spray Market Facts & Figures by Region
3.6.1 Asia Pacific Anti-viral Nasal Spray Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Anti-viral Nasal Spray Sales by Region (2021–2032)
3.6.3 Asia Pacific Anti-viral Nasal Spray Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Anti-viral Nasal Spray Market Facts & Figures by Country
3.7.1 Latin America Anti-viral Nasal Spray Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Anti-viral Nasal Spray Sales by Country (2021–2032)
3.7.3 Latin America Anti-viral Nasal Spray Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Anti-viral Nasal Spray Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-viral Nasal Spray Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Anti-viral Nasal Spray Sales by Country (2021–2032)
3.8.3 Middle East and Africa Anti-viral Nasal Spray Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment Effective Protection Duration
4.1 Global Anti-viral Nasal Spray Sales Effective Protection Duration (2021–2032)
4.1.1 Global Anti-viral Nasal Spray Sales Effective Protection Duration (2021–2026)
4.1.2 Global Anti-viral Nasal Spray Sales Effective Protection Duration (2027–2032)
4.1.3 Global Anti-viral Nasal Spray Sales Market Share Effective Protection Duration (2021–2032)
4.2 Global Anti-viral Nasal Spray Revenue Effective Protection Duration (2021–2032)
4.2.1 Global Anti-viral Nasal Spray Revenue Effective Protection Duration (2021–2026)
4.2.2 Global Anti-viral Nasal Spray Revenue Effective Protection Duration (2027–2032)
4.2.3 Global Anti-viral Nasal Spray Revenue Market Share Effective Protection Duration (2021–2032)
4.3 Global Anti-viral Nasal Spray Price Effective Protection Duration (2021–2032)
5 Segment by Application
5.1 Global Anti-viral Nasal Spray Sales by Application (2021–2032)
5.1.1 Global Anti-viral Nasal Spray Sales by Application (2021–2026)
5.1.2 Global Anti-viral Nasal Spray Sales by Application (2027–2032)
5.1.3 Global Anti-viral Nasal Spray Sales Market Share by Application (2021–2032)
5.2 Global Anti-viral Nasal Spray Revenue by Application (2021–2032)
5.2.1 Global Anti-viral Nasal Spray Revenue by Application (2021–2026)
5.2.2 Global Anti-viral Nasal Spray Revenue by Application (2027–2032)
5.2.3 Global Anti-viral Nasal Spray Revenue Market Share by Application (2021–2032)
5.3 Global Anti-viral Nasal Spray Price by Application (2021–2032)
6 Key Companies Profiled
6.1 pHOXBIO
6.1.1 pHOXBIO Company Information
6.1.2 pHOXBIO Description and Business Overview
6.1.3 pHOXBIO Anti-viral Nasal Spray Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 pHOXBIO Anti-viral Nasal Spray Product Portfolio
6.1.5 pHOXBIO Recent Developments/Updates
6.2 Dual
6.2.1 Dual Company Information
6.2.2 Dual Description and Business Overview
6.2.3 Dual Anti-viral Nasal Spray Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Dual Anti-viral Nasal Spray Product Portfolio
6.2.5 Dual Recent Developments/Updates
6.3 Birmingham Biotech
6.3.1 Birmingham Biotech Company Information
6.3.2 Birmingham Biotech Description and Business Overview
6.3.3 Birmingham Biotech Anti-viral Nasal Spray Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Birmingham Biotech Anti-viral Nasal Spray Product Portfolio
6.3.5 Birmingham Biotech Recent Developments/Updates
6.4 Salvacion
6.4.1 Salvacion Company Information
6.4.2 Salvacion Description and Business Overview
6.4.3 Salvacion Anti-viral Nasal Spray Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Salvacion Anti-viral Nasal Spray Product Portfolio
6.4.5 Salvacion Recent Developments/Updates
6.5 BioSure
6.5.1 BioSure Company Information
6.5.2 BioSure Description and Business Overview
6.5.3 BioSure Anti-viral Nasal Spray Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 BioSure Anti-viral Nasal Spray Product Portfolio
6.5.5 BioSure Recent Developments/Updates
6.6 Profispray
6.6.1 Profispray Company Information
6.6.2 Profispray Description and Business Overview
6.6.3 Profispray Anti-viral Nasal Spray Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Profispray Anti-viral Nasal Spray Product Portfolio
6.6.5 Profispray Recent Developments/Updates
6.7 EM Pharma
6.7.1 EM Pharma Company Information
6.7.2 EM Pharma Description and Business Overview
6.7.3 EM Pharma Anti-viral Nasal Spray Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 EM Pharma Anti-viral Nasal Spray Product Portfolio
6.7.5 EM Pharma Recent Developments/Updates
6.8 Virx
6.8.1 Virx Company Information
6.8.2 Virx Description and Business Overview
6.8.3 Virx Anti-viral Nasal Spray Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Virx Anti-viral Nasal Spray Product Portfolio
6.8.5 Virx Recent Developments/Updates
6.9 Novasci
6.9.1 Novasci Company Information
6.9.2 Novasci Description and Business Overview
6.9.3 Novasci Anti-viral Nasal Spray Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Novasci Anti-viral Nasal Spray Product Portfolio
6.9.5 Novasci Recent Developments/Updates
6.10 Guangzhou Apollobio
6.10.1 Guangzhou Apollobio Company Information
6.10.2 Guangzhou Apollobio Description and Business Overview
6.10.3 Guangzhou Apollobio Anti-viral Nasal Spray Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Guangzhou Apollobio Anti-viral Nasal Spray Product Portfolio
6.10.5 Guangzhou Apollobio Recent Developments/Updates
6.11 Blue Sail Medical
6.11.1 Blue Sail Medical Company Information
6.11.2 Blue Sail Medical Description and Business Overview
6.11.3 Blue Sail Medical Anti-viral Nasal Spray Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Blue Sail Medical Anti-viral Nasal Spray Product Portfolio
6.11.5 Blue Sail Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-viral Nasal Spray Industry Chain Analysis
7.2 Anti-viral Nasal Spray Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-viral Nasal Spray Production Mode & Process Analysis
7.4 Anti-viral Nasal Spray Sales and Marketing
7.4.1 Anti-viral Nasal Spray Sales Channels
7.4.2 Anti-viral Nasal Spray Distributors
7.5 Anti-viral Nasal Spray Customer Analysis
8 Anti-viral Nasal Spray Market Dynamics
8.1 Anti-viral Nasal Spray Industry Trends
8.2 Anti-viral Nasal Spray Market Drivers
8.3 Anti-viral Nasal Spray Market Challenges
8.4 Anti-viral Nasal Spray Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Anti-viral Nasal Spray Market Value Effective Protection Duration (US$ Million), 2025 vs 2032
Table 2. Global Anti-viral Nasal Spray Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Anti-viral Nasal Spray Market Competitive Situation by Manufacturers in 2025
Table 4. Global Anti-viral Nasal Spray Sales (KG) of Key Manufacturers (2021–2026)
Table 5. Global Anti-viral Nasal Spray Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Anti-viral Nasal Spray Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Anti-viral Nasal Spray Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Anti-viral Nasal Spray Average Price (US$/G) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Anti-viral Nasal Spray, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Anti-viral Nasal Spray, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Anti-viral Nasal Spray, Product Types and Applications
Table 12. Global Key Manufacturers of Anti-viral Nasal Spray, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-viral Nasal Spray Companies by Tier (Tier 1, Tier 2, Tier 3), based on Anti-viral Nasal Spray Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-viral Nasal Spray Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Anti-viral Nasal Spray Sales by Region (KG), 2021–2026
Table 18. Global Anti-viral Nasal Spray Sales Market Share by Region (2021–2026)
Table 19. Global Anti-viral Nasal Spray Sales by Region (KG), 2027–2032
Table 20. Global Anti-viral Nasal Spray Sales Market Share by Region (2027–2032)
Table 21. Global Anti-viral Nasal Spray Revenue by Region (US$ Million), 2021–2026
Table 22. Global Anti-viral Nasal Spray Revenue Market Share by Region (2021–2026)
Table 23. Global Anti-viral Nasal Spray Revenue by Region (US$ Million), 2027–2032
Table 24. Global Anti-viral Nasal Spray Revenue Market Share by Region (2027–2032)
Table 25. North America Anti-viral Nasal Spray Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Anti-viral Nasal Spray Sales by Country (KG), 2021–2026
Table 27. North America Anti-viral Nasal Spray Sales by Country (KG), 2027–2032
Table 28. North America Anti-viral Nasal Spray Revenue by Country (US$ Million), 2021–2026
Table 29. North America Anti-viral Nasal Spray Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Anti-viral Nasal Spray Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Anti-viral Nasal Spray Sales by Country (KG), 2021–2026
Table 32. Europe Anti-viral Nasal Spray Sales by Country (KG), 2027–2032
Table 33. Europe Anti-viral Nasal Spray Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Anti-viral Nasal Spray Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Anti-viral Nasal Spray Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Anti-viral Nasal Spray Sales by Region (KG), 2021–2026
Table 37. Asia Pacific Anti-viral Nasal Spray Sales by Region (KG), 2027–2032
Table 38. Asia Pacific Anti-viral Nasal Spray Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Anti-viral Nasal Spray Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Anti-viral Nasal Spray Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Anti-viral Nasal Spray Sales by Country (KG), 2021–2026
Table 42. Latin America Anti-viral Nasal Spray Sales by Country (KG), 2027–2032
Table 43. Latin America Anti-viral Nasal Spray Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Anti-viral Nasal Spray Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Anti-viral Nasal Spray Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Anti-viral Nasal Spray Sales by Country (KG), 2021–2026
Table 47. Middle East and Africa Anti-viral Nasal Spray Sales by Country (KG), 2027–2032
Table 48. Middle East and Africa Anti-viral Nasal Spray Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Anti-viral Nasal Spray Revenue by Country (US$ Million), 2027–2032
Table 50. Global Anti-viral Nasal Spray Sales (KG) Effective Protection Duration (2021–2026)
Table 51. Global Anti-viral Nasal Spray Sales (KG) Effective Protection Duration (2027–2032)
Table 52. Global Anti-viral Nasal Spray Sales Market Share Effective Protection Duration (2021–2026)
Table 53. Global Anti-viral Nasal Spray Sales Market Share Effective Protection Duration (2027–2032)
Table 54. Global Anti-viral Nasal Spray Revenue (US$ Million) Effective Protection Duration (2021–2026)
Table 55. Global Anti-viral Nasal Spray Revenue (US$ Million) Effective Protection Duration (2027–2032)
Table 56. Global Anti-viral Nasal Spray Revenue Market Share Effective Protection Duration (2021–2026)
Table 57. Global Anti-viral Nasal Spray Revenue Market Share Effective Protection Duration (2027–2032)
Table 58. Global Anti-viral Nasal Spray Price (US$/G) Effective Protection Duration (2021–2026)
Table 59. Global Anti-viral Nasal Spray Price (US$/G) Effective Protection Duration (2027–2032)
Table 60. Global Anti-viral Nasal Spray Sales (KG) by Application (2021–2026)
Table 61. Global Anti-viral Nasal Spray Sales (KG) by Application (2027–2032)
Table 62. Global Anti-viral Nasal Spray Sales Market Share by Application (2021–2026)
Table 63. Global Anti-viral Nasal Spray Sales Market Share by Application (2027–2032)
Table 64. Global Anti-viral Nasal Spray Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Anti-viral Nasal Spray Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Anti-viral Nasal Spray Revenue Market Share by Application (2021–2026)
Table 67. Global Anti-viral Nasal Spray Revenue Market Share by Application (2027–2032)
Table 68. Global Anti-viral Nasal Spray Price (US$/G) by Application (2021–2026)
Table 69. Global Anti-viral Nasal Spray Price (US$/G) by Application (2027–2032)
Table 70. pHOXBIO Company Information
Table 71. pHOXBIO Description and Business Overview
Table 72. pHOXBIO Anti-viral Nasal Spray Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 73. pHOXBIO Anti-viral Nasal Spray Product
Table 74. pHOXBIO Recent Developments/Updates
Table 75. Dual Company Information
Table 76. Dual Description and Business Overview
Table 77. Dual Anti-viral Nasal Spray Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 78. Dual Anti-viral Nasal Spray Product
Table 79. Dual Recent Developments/Updates
Table 80. Birmingham Biotech Company Information
Table 81. Birmingham Biotech Description and Business Overview
Table 82. Birmingham Biotech Anti-viral Nasal Spray Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 83. Birmingham Biotech Anti-viral Nasal Spray Product
Table 84. Birmingham Biotech Recent Developments/Updates
Table 85. Salvacion Company Information
Table 86. Salvacion Description and Business Overview
Table 87. Salvacion Anti-viral Nasal Spray Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 88. Salvacion Anti-viral Nasal Spray Product
Table 89. Salvacion Recent Developments/Updates
Table 90. BioSure Company Information
Table 91. BioSure Description and Business Overview
Table 92. BioSure Anti-viral Nasal Spray Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 93. BioSure Anti-viral Nasal Spray Product
Table 94. BioSure Recent Developments/Updates
Table 95. Profispray Company Information
Table 96. Profispray Description and Business Overview
Table 97. Profispray Anti-viral Nasal Spray Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 98. Profispray Anti-viral Nasal Spray Product
Table 99. Profispray Recent Developments/Updates
Table 100. EM Pharma Company Information
Table 101. EM Pharma Description and Business Overview
Table 102. EM Pharma Anti-viral Nasal Spray Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 103. EM Pharma Anti-viral Nasal Spray Product
Table 104. EM Pharma Recent Developments/Updates
Table 105. Virx Company Information
Table 106. Virx Description and Business Overview
Table 107. Virx Anti-viral Nasal Spray Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 108. Virx Anti-viral Nasal Spray Product
Table 109. Virx Recent Developments/Updates
Table 110. Novasci Company Information
Table 111. Novasci Description and Business Overview
Table 112. Novasci Anti-viral Nasal Spray Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 113. Novasci Anti-viral Nasal Spray Product
Table 114. Novasci Recent Developments/Updates
Table 115. Guangzhou Apollobio Company Information
Table 116. Guangzhou Apollobio Description and Business Overview
Table 117. Guangzhou Apollobio Anti-viral Nasal Spray Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 118. Guangzhou Apollobio Anti-viral Nasal Spray Product
Table 119. Guangzhou Apollobio Recent Developments/Updates
Table 120. Blue Sail Medical Company Information
Table 121. Blue Sail Medical Description and Business Overview
Table 122. Blue Sail Medical Anti-viral Nasal Spray Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 123. Blue Sail Medical Anti-viral Nasal Spray Product
Table 124. Blue Sail Medical Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Anti-viral Nasal Spray Distributors List
Table 128. Anti-viral Nasal Spray Customers List
Table 129. Anti-viral Nasal Spray Market Trends
Table 130. Anti-viral Nasal Spray Market Drivers
Table 131. Anti-viral Nasal Spray Market Challenges
Table 132. Anti-viral Nasal Spray Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anti-viral Nasal Spray
Figure 2. Global Anti-viral Nasal Spray Market Value Effective Protection Duration (US$ Million), 2021–2032
Figure 3. Global Anti-viral Nasal Spray Market Share Effective Protection Duration: 2025 & 2032
Figure 4. 6 hours or less Product Picture
Figure 5. 6 hours or more Product Picture
Figure 6. Global Anti-viral Nasal Spray Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Anti-viral Nasal Spray Market Share by Application: 2025 & 2032
Figure 8. Children
Figure 9. Adults
Figure 10. Elderly
Figure 11. Global Anti-viral Nasal Spray Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Anti-viral Nasal Spray Market Size (US$ Million), 2021–2032
Figure 13. Global Anti-viral Nasal Spray Sales (KG), 2021–2032
Figure 14. Global Anti-viral Nasal Spray Average Price (US$/G), 2021–2032
Figure 15. Anti-viral Nasal Spray Report Years Considered
Figure 16. Anti-viral Nasal Spray Sales Share by Manufacturers in 2025
Figure 17. Global Anti-viral Nasal Spray Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Anti-viral Nasal Spray Players: Market Share by Revenue in Anti-viral Nasal Spray in 2025
Figure 19. Anti-viral Nasal Spray Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Anti-viral Nasal Spray Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Anti-viral Nasal Spray Sales Market Share by Country (2021–2032)
Figure 22. North America Anti-viral Nasal Spray Revenue Market Share by Country (2021–2032)
Figure 23. United States Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Anti-viral Nasal Spray Sales Market Share by Country (2021–2032)
Figure 26. Europe Anti-viral Nasal Spray Revenue Market Share by Country (2021–2032)
Figure 27. Germany Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Anti-viral Nasal Spray Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Anti-viral Nasal Spray Revenue Market Share by Region (2021–2032)
Figure 34. China Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Anti-viral Nasal Spray Sales Market Share by Country (2021–2032)
Figure 42. Latin America Anti-viral Nasal Spray Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Anti-viral Nasal Spray Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Anti-viral Nasal Spray Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Anti-viral Nasal Spray Effective Protection Duration (2021–2032)
Figure 53. Global Revenue Market Share of Anti-viral Nasal Spray Effective Protection Duration (2021–2032)
Figure 54. Global Anti-viral Nasal Spray Price (US$/G) Effective Protection Duration (2021–2032)
Figure 55. Global Sales Market Share of Anti-viral Nasal Spray by Application (2021–2032)
Figure 56. Global Revenue Market Share of Anti-viral Nasal Spray by Application (2021–2032)
Figure 57. Global Anti-viral Nasal Spray Price (US$/G) by Application (2021–2032)
Figure 58. Anti-viral Nasal Spray Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Anti-viral Nasal Spray Market Value Effective Protection Duration (US$ Million), 2025 vs 2032
Table 2. Global Anti-viral Nasal Spray Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Anti-viral Nasal Spray Market Competitive Situation by Manufacturers in 2025
Table 4. Global Anti-viral Nasal Spray Sales (KG) of Key Manufacturers (2021–2026)
Table 5. Global Anti-viral Nasal Spray Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Anti-viral Nasal Spray Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Anti-viral Nasal Spray Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Anti-viral Nasal Spray Average Price (US$/G) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Anti-viral Nasal Spray, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Anti-viral Nasal Spray, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Anti-viral Nasal Spray, Product Types and Applications
Table 12. Global Key Manufacturers of Anti-viral Nasal Spray, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-viral Nasal Spray Companies by Tier (Tier 1, Tier 2, Tier 3), based on Anti-viral Nasal Spray Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-viral Nasal Spray Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Anti-viral Nasal Spray Sales by Region (KG), 2021–2026
Table 18. Global Anti-viral Nasal Spray Sales Market Share by Region (2021–2026)
Table 19. Global Anti-viral Nasal Spray Sales by Region (KG), 2027–2032
Table 20. Global Anti-viral Nasal Spray Sales Market Share by Region (2027–2032)
Table 21. Global Anti-viral Nasal Spray Revenue by Region (US$ Million), 2021–2026
Table 22. Global Anti-viral Nasal Spray Revenue Market Share by Region (2021–2026)
Table 23. Global Anti-viral Nasal Spray Revenue by Region (US$ Million), 2027–2032
Table 24. Global Anti-viral Nasal Spray Revenue Market Share by Region (2027–2032)
Table 25. North America Anti-viral Nasal Spray Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Anti-viral Nasal Spray Sales by Country (KG), 2021–2026
Table 27. North America Anti-viral Nasal Spray Sales by Country (KG), 2027–2032
Table 28. North America Anti-viral Nasal Spray Revenue by Country (US$ Million), 2021–2026
Table 29. North America Anti-viral Nasal Spray Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Anti-viral Nasal Spray Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Anti-viral Nasal Spray Sales by Country (KG), 2021–2026
Table 32. Europe Anti-viral Nasal Spray Sales by Country (KG), 2027–2032
Table 33. Europe Anti-viral Nasal Spray Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Anti-viral Nasal Spray Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Anti-viral Nasal Spray Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Anti-viral Nasal Spray Sales by Region (KG), 2021–2026
Table 37. Asia Pacific Anti-viral Nasal Spray Sales by Region (KG), 2027–2032
Table 38. Asia Pacific Anti-viral Nasal Spray Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Anti-viral Nasal Spray Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Anti-viral Nasal Spray Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Anti-viral Nasal Spray Sales by Country (KG), 2021–2026
Table 42. Latin America Anti-viral Nasal Spray Sales by Country (KG), 2027–2032
Table 43. Latin America Anti-viral Nasal Spray Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Anti-viral Nasal Spray Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Anti-viral Nasal Spray Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Anti-viral Nasal Spray Sales by Country (KG), 2021–2026
Table 47. Middle East and Africa Anti-viral Nasal Spray Sales by Country (KG), 2027–2032
Table 48. Middle East and Africa Anti-viral Nasal Spray Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Anti-viral Nasal Spray Revenue by Country (US$ Million), 2027–2032
Table 50. Global Anti-viral Nasal Spray Sales (KG) Effective Protection Duration (2021–2026)
Table 51. Global Anti-viral Nasal Spray Sales (KG) Effective Protection Duration (2027–2032)
Table 52. Global Anti-viral Nasal Spray Sales Market Share Effective Protection Duration (2021–2026)
Table 53. Global Anti-viral Nasal Spray Sales Market Share Effective Protection Duration (2027–2032)
Table 54. Global Anti-viral Nasal Spray Revenue (US$ Million) Effective Protection Duration (2021–2026)
Table 55. Global Anti-viral Nasal Spray Revenue (US$ Million) Effective Protection Duration (2027–2032)
Table 56. Global Anti-viral Nasal Spray Revenue Market Share Effective Protection Duration (2021–2026)
Table 57. Global Anti-viral Nasal Spray Revenue Market Share Effective Protection Duration (2027–2032)
Table 58. Global Anti-viral Nasal Spray Price (US$/G) Effective Protection Duration (2021–2026)
Table 59. Global Anti-viral Nasal Spray Price (US$/G) Effective Protection Duration (2027–2032)
Table 60. Global Anti-viral Nasal Spray Sales (KG) by Application (2021–2026)
Table 61. Global Anti-viral Nasal Spray Sales (KG) by Application (2027–2032)
Table 62. Global Anti-viral Nasal Spray Sales Market Share by Application (2021–2026)
Table 63. Global Anti-viral Nasal Spray Sales Market Share by Application (2027–2032)
Table 64. Global Anti-viral Nasal Spray Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Anti-viral Nasal Spray Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Anti-viral Nasal Spray Revenue Market Share by Application (2021–2026)
Table 67. Global Anti-viral Nasal Spray Revenue Market Share by Application (2027–2032)
Table 68. Global Anti-viral Nasal Spray Price (US$/G) by Application (2021–2026)
Table 69. Global Anti-viral Nasal Spray Price (US$/G) by Application (2027–2032)
Table 70. pHOXBIO Company Information
Table 71. pHOXBIO Description and Business Overview
Table 72. pHOXBIO Anti-viral Nasal Spray Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 73. pHOXBIO Anti-viral Nasal Spray Product
Table 74. pHOXBIO Recent Developments/Updates
Table 75. Dual Company Information
Table 76. Dual Description and Business Overview
Table 77. Dual Anti-viral Nasal Spray Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 78. Dual Anti-viral Nasal Spray Product
Table 79. Dual Recent Developments/Updates
Table 80. Birmingham Biotech Company Information
Table 81. Birmingham Biotech Description and Business Overview
Table 82. Birmingham Biotech Anti-viral Nasal Spray Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 83. Birmingham Biotech Anti-viral Nasal Spray Product
Table 84. Birmingham Biotech Recent Developments/Updates
Table 85. Salvacion Company Information
Table 86. Salvacion Description and Business Overview
Table 87. Salvacion Anti-viral Nasal Spray Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 88. Salvacion Anti-viral Nasal Spray Product
Table 89. Salvacion Recent Developments/Updates
Table 90. BioSure Company Information
Table 91. BioSure Description and Business Overview
Table 92. BioSure Anti-viral Nasal Spray Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 93. BioSure Anti-viral Nasal Spray Product
Table 94. BioSure Recent Developments/Updates
Table 95. Profispray Company Information
Table 96. Profispray Description and Business Overview
Table 97. Profispray Anti-viral Nasal Spray Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 98. Profispray Anti-viral Nasal Spray Product
Table 99. Profispray Recent Developments/Updates
Table 100. EM Pharma Company Information
Table 101. EM Pharma Description and Business Overview
Table 102. EM Pharma Anti-viral Nasal Spray Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 103. EM Pharma Anti-viral Nasal Spray Product
Table 104. EM Pharma Recent Developments/Updates
Table 105. Virx Company Information
Table 106. Virx Description and Business Overview
Table 107. Virx Anti-viral Nasal Spray Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 108. Virx Anti-viral Nasal Spray Product
Table 109. Virx Recent Developments/Updates
Table 110. Novasci Company Information
Table 111. Novasci Description and Business Overview
Table 112. Novasci Anti-viral Nasal Spray Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 113. Novasci Anti-viral Nasal Spray Product
Table 114. Novasci Recent Developments/Updates
Table 115. Guangzhou Apollobio Company Information
Table 116. Guangzhou Apollobio Description and Business Overview
Table 117. Guangzhou Apollobio Anti-viral Nasal Spray Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 118. Guangzhou Apollobio Anti-viral Nasal Spray Product
Table 119. Guangzhou Apollobio Recent Developments/Updates
Table 120. Blue Sail Medical Company Information
Table 121. Blue Sail Medical Description and Business Overview
Table 122. Blue Sail Medical Anti-viral Nasal Spray Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
Table 123. Blue Sail Medical Anti-viral Nasal Spray Product
Table 124. Blue Sail Medical Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Anti-viral Nasal Spray Distributors List
Table 128. Anti-viral Nasal Spray Customers List
Table 129. Anti-viral Nasal Spray Market Trends
Table 130. Anti-viral Nasal Spray Market Drivers
Table 131. Anti-viral Nasal Spray Market Challenges
Table 132. Anti-viral Nasal Spray Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anti-viral Nasal Spray
Figure 2. Global Anti-viral Nasal Spray Market Value Effective Protection Duration (US$ Million), 2021–2032
Figure 3. Global Anti-viral Nasal Spray Market Share Effective Protection Duration: 2025 & 2032
Figure 4. 6 hours or less Product Picture
Figure 5. 6 hours or more Product Picture
Figure 6. Global Anti-viral Nasal Spray Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Anti-viral Nasal Spray Market Share by Application: 2025 & 2032
Figure 8. Children
Figure 9. Adults
Figure 10. Elderly
Figure 11. Global Anti-viral Nasal Spray Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Anti-viral Nasal Spray Market Size (US$ Million), 2021–2032
Figure 13. Global Anti-viral Nasal Spray Sales (KG), 2021–2032
Figure 14. Global Anti-viral Nasal Spray Average Price (US$/G), 2021–2032
Figure 15. Anti-viral Nasal Spray Report Years Considered
Figure 16. Anti-viral Nasal Spray Sales Share by Manufacturers in 2025
Figure 17. Global Anti-viral Nasal Spray Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Anti-viral Nasal Spray Players: Market Share by Revenue in Anti-viral Nasal Spray in 2025
Figure 19. Anti-viral Nasal Spray Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Anti-viral Nasal Spray Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Anti-viral Nasal Spray Sales Market Share by Country (2021–2032)
Figure 22. North America Anti-viral Nasal Spray Revenue Market Share by Country (2021–2032)
Figure 23. United States Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Anti-viral Nasal Spray Sales Market Share by Country (2021–2032)
Figure 26. Europe Anti-viral Nasal Spray Revenue Market Share by Country (2021–2032)
Figure 27. Germany Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Anti-viral Nasal Spray Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Anti-viral Nasal Spray Revenue Market Share by Region (2021–2032)
Figure 34. China Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Anti-viral Nasal Spray Sales Market Share by Country (2021–2032)
Figure 42. Latin America Anti-viral Nasal Spray Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Anti-viral Nasal Spray Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Anti-viral Nasal Spray Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Anti-viral Nasal Spray Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Anti-viral Nasal Spray Effective Protection Duration (2021–2032)
Figure 53. Global Revenue Market Share of Anti-viral Nasal Spray Effective Protection Duration (2021–2032)
Figure 54. Global Anti-viral Nasal Spray Price (US$/G) Effective Protection Duration (2021–2032)
Figure 55. Global Sales Market Share of Anti-viral Nasal Spray by Application (2021–2032)
Figure 56. Global Revenue Market Share of Anti-viral Nasal Spray by Application (2021–2032)
Figure 57. Global Anti-viral Nasal Spray Price (US$/G) by Application (2021–2032)
Figure 58. Anti-viral Nasal Spray Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232